Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Apache Indian who wrote (640)	8/4/1999 3:56:00 PM
From: Mike McFarland	Read Replies (2) of 1494

"Merz + Co. GmbH & Co. of Frankfurt, Germany (Merz) has agreed to lend the company up to $1.5 million to support continuing late-stage clinical development of Memantine. The company has received an initial installment from Merz in the amount of $500,000. The loan is interest bearing and may be converted to equity at Merz's discretion. Use of the funds is restricted to support the company's Phase IIB clinical trial of Memantine for neuropathic pain." biz.yahoo.com This may explain the recent run-up. Does anybody think the private offering for shares below a buck may not go through. If not...then the current price looks more attractive for folks--could the loan be a signal that the private offering is not going to occur? Hope we do not see any sell on news tommorrow--new support at 1 1/2?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next